Testing a numbing medication to reduce pain drug use in sickle cell crisis

This trial is testing whether lidocaine, a numbing medication given through an IV, can help reduce how much opioid painkiller (like morphine) patients need during a severe vaso-occlusive crisis — the intense pain episodes that come with sickle cell disease. Half of participants will receive the medication plus standard care, and the other half will receive a placebo (saline solution) plus standard care. Researchers want to see if this medication can make pain more manageable while using less opioid medication.

Sickle cell patients in severe pain episodes currently need large amounts of opioid painkillers, which carry risks of dependence and side effects. This trial is exploring whether adding the medication could ease pain better with fewer opioids, offering a safer pain management option.